PDL1 / B7H3 Bispecific Binding Antibody and Its Uses

TW202639594APending Publication Date: 2026-10-01SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146512
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-21
Filing Date
2025-11-27
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078594_001
    Figure TWG2TA001078594_001
  • Figure TWG2TA001078594_002
    Figure TWG2TA001078594_002
  • Figure TWG2TA001078594_003
    Figure TWG2TA001078594_003
Patent Text Reader

Abstract

This invention relates to the field of disease treatment, specifically to a bispecific antibody targeting PDL1 and B7H3, a nucleic acid molecule encoding the bispecific antibody, and a method for preparing the bispecific antibody. This invention also relates to the application of the bispecific antibody in tumor treatment.
Need to check novelty before this filing date? Find Prior Art